Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model

scientific article published on January 2015

Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3233/JAD-141722
P932PMC publication ID4486520
P698PubMed publication ID25649650

P50authorRobert A RissmanQ88618697
P2093author name stringKenner C Rice
Cheng Zhang
Louise Monte
Ching-Chang Kuo
Setareh H Moghadam
P2860cites workNeuropeptide abnormalities in patients with early Alzheimer diseaseQ73191849
Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer diseaseQ21144713
Free radicals and antioxidants in normal physiological functions and human diseaseQ21710698
S-glutathionylation: from molecular mechanisms to health outcomesQ30398587
Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesisQ33607471
Oxidative stress in the progression of Alzheimer disease in the frontal cortexQ33680790
Adverse stress, hippocampal networks, and Alzheimer's diseaseQ33708011
Oxidative stress and Alzheimer diseaseQ33841850
S-Glutathionyl quantification in the attomole range using glutaredoxin-3-catalyzed cysteine derivatization and capillary gel electrophoresis with laser-induced fluorescence detectionQ33993016
Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegenerationQ34071097
The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.Q34182381
Glutathione peroxidase enzyme activity in agingQ34240689
Age-dependent and tissue-related glutathione redox status in a mouse model of Alzheimer's diseaseQ34459616
Localizing movement-related primary sensorimotor cortices with multi-band EEG frequency changes and functional MRIQ34465996
Prediction of S-glutathionylated proteins progression in Alzheimer's transgenic mouse model using principle component analysisQ34466540
Principal component analysis reveals age-related and muscle-type-related differences in protein carbonyl profiles of muscle mitochondriaQ34570379
Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factorQ34644508
Detection and quantification of 8-hydroxy-2'-deoxyguanosine in Alzheimer's transgenic mouse urine using capillary electrophoresis.Q34742674
Characterization of ATP alternations in an Alzheimer's disease transgenic mouse modelQ35007956
Role of CRH in the pathogenesis of dementia of Alzheimer's type and other dementias.Q35023154
Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's diseaseQ35458379
Cellular Redox: A Modulator of Intestinal Epithelial Cell ProliferationQ35538744
Corticotropin-releasing factor receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregationQ35924838
Glutathione in cerebral microvascular endothelial biology and pathobiology: implications for brain homeostasisQ36057680
The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology.Q36399313
Oxidative stress and lysosomes: CNS-related consequences and implications for lysosomal enhancement strategies and induction of autophagyQ36399799
Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?Q36499640
Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress.Q36841921
Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer diseaseQ36984455
Causes and consequences of cysteine S-glutathionylationQ37168359
CRF system recruitment mediates dark side of compulsive eatingQ37446510
Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolismQ37603401
Role of the p53 Family in Stabilizing the Genome and Preventing PolyploidizationQ37778010
Elevation of glutathione as a therapeutic strategy in Alzheimer diseaseQ37947939
Oxidative stress and the ageing endocrine systemQ38084435
Effect of protein glutathionylation on neuronal cytoskeleton: a potential link to neurodegenerationQ39518027
Glutathione peroxidase activity is neuroprotective in models of Huntington's diseaseQ40129680
Oxidative stress hypothesis in Alzheimer's diseaseQ41482152
Long-Term Electrophysiological and Behavioral Analysis on the Improvement of Visual Working Memory Load, Training Gains, and Transfer BenefitsQ41778000
Elevation by oxidative stress and aging of hypothalamic-pituitary-adrenal activity in rats and its prevention by vitamin eQ42115631
Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets of male C57BL/6 mice are associated with diabetes induced by multiple low doses of streptozotocinQ42465882
Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairmentQ42963006
The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stressQ44285597
Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation.Q44934002
Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonistsQ45039920
Spatial learning impairments in PLB1Triple knock-in Alzheimer mice are task-specific and age-dependent.Q45924774
Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouseQ46125569
Proneness to psychological distress is associated with risk of Alzheimer's diseaseQ47333653
Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's diseaseQ48398841
Two-dimensional nitrosylated protein fingerprinting by using poly (methyl methacrylate) microchipsQ48450021
Distress proneness and cognitive decline in a population of older persons.Q50748610
Impaired glutathione peroxidase activity accounts for the age-related accumulation of hydrogen peroxide in activated human neutrophils.Q52243066
Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy.Q53193396
P433issue2
P921main subjectAlzheimer's diseaseQ11081
P304page(s)639-650
P577publication date2015-01-01
P1433published inJournal of Alzheimer's DiseaseQ6294755
P1476titleCorticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model
P478volume45

Reverse relations

cites work (P2860)
Q38657509Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer's disease mice.
Q60313606Motor and Nonmotor Symptoms of Parkinson’s Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability?
Q55177547The relationship between stress and Alzheimer's disease.

Search more.